Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 5:22 pm Sale | 2022-01-31 | 13G | MEI Pharma, Inc. MEIP | BlackRock Inc. BLK | 331,850 4.990% | -2,643 (-0.79%) | Filing History |
| 2022-01-31 5:49 pm Sale | 2021-12-31 | 13G | MEI Pharma, Inc. MEIP | BlackRock Inc. BLK | 334,494 5.900% | -14,890 (-4.26%) | Filing History |
| 2021-02-16 3:44 pm Unchanged | 2020-12-31 | 13G | MEI Pharma, Inc. MEIP | PERCEPTIVE ADVISORS LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-16 08:32 am Purchase | 2020-12-31 | 13G | MEI Pharma, Inc. MEIP | UBS Oncology Impact Fund L.P. | 506,893 9.000% | 194,393 (+62.21%) | Filing History |
| 2021-02-12 4:30 pm Sale | 2020-12-31 | 13G | MEI Pharma, Inc. MEIP | Vivo Opportunity LLC | 165,017 2.800% | -368,606 (-69.08%) | Filing History |
| 2021-02-11 5:29 pm Sale | 2020-12-31 | 13G | MEI Pharma, Inc. MEIP | BIOTECHNOLOGY VALUE FUND L P | 279,466 4.900% | -64,856 (-18.84%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | MEI Pharma, Inc. MEIP | BlackRock Inc. BLK | 349,384 6.200% | 349,384 (New Position) | Filing History |